Drowsiness methadone

Oral In 10 methadone-maintained inpatients, DXM (120, 240, and 480 mg/day for 4 days each to reduce methadone tolerance) induced some drowsiness no changes in subjective effects or ARCI several patients reported intoxication at the highest dose212... 

In the second study there were 174 patients in two similar experimental groups in whom injectable rather than inhaled heroin was used (5). A response to treatment was defined as at least a 40% improvement in physical, mental, or social domains of quality of life, if not accompanied by a substantial (over 20%) increase in the use of another illicit drug, such as cocaine or amphetamines. After 12 months those who took methadone and heroin (smoked or injected) had significantly better outcomes. The incidences of adverse effects (constipation and drowsiness) were similar in all the groups. However, owing to the limitations of the study and the complex nature of drug dependence, the therapeutic outcomes could not be justifiably and solely attributed to the specific drug(s). 

IMATINIB ANALGESICS-OPIOIDS May cause t plasma concentrations, with a risk of toxic effects of codeine, dextromethorphan, hydroxycodone, methadone, morphine, oxycodone, pethidine and tramadol Inhibition of CYP2D6-mediated metabolism of these opioids Monitor for clinical efficacy and toxicity. Warn patients to report t drowsiness, malaise or anorexia. Measure amylase and lipase levels if toxicity is suspected. Tramadol causes less respiratory depression than other opiates, but need to monitor BP and blood counts, and advise patients to report wheezing, loss of appetite and fainting attacks. Need to consider 1 dose. Methadone may cause Q-T prolongation the CHM has recommended that patients with heart and liver disease who are on methadone should be carefully monitored for heart conduction abnormalities such as Q-T prolongation on ECG as they may lead to sudden death. Also need to monitor patients on more than 100 mg methadone daily and thus an t in plasma concentrations necessitates close monitoring of cardiac and respiratory function... 

In the last 32 there were significant improvements in pain intensity, nausea and vomiting, constipation, and drowsiness, with a 20% increase in methadone dose over and above the recommended starting dose. 

Opiates Pupillary constriction, constipation, drowsiness, coma, slurred speech, respiratory depression, Flu-like muscle aches, nausea or vomiting, yawning, piloerection, [animation, rhinorrhea, fever, insomnia, pupillary dilation Opiates receptors, locus cereleus pathway (noradrenergic) Naloxone (short half-life), naltrexone (longer half-life), donidine (ease withdrawal), methadone, LAMM (Levo-ac-aretyl-methadol) substitute addictions,longer withdrawal period Males > Females 3 1 TB, AIDS, hepatitis, pulmonary hypertension, pneumonia... 

Methadone causes drowsiness, lightheadedness, dizziness, and a transient drop in blood pressure. Therefore, the nurse should discuss how to prevent orthostatic hypotension. Methadone is used to treat heroin withdrawal. 

Methadone is frequently used to treat heroin, codeine, hydrocodone, oxycodone, and morphine addictions. Methadone when used as prescribed, is safe and effective and does not cause euphoric sensations but does relieve physical withdrawal symptoms and reduces physiologic cravings. Methadone does have side effects which may be intolerable to some patients. They include constipation, water retention, drowsiness, skin rash, excessive sweating, and change in sex drive. Methadone has been used successfully in the treatment of opioid addiction for over 30 years. 

Musculoskeletal A 21-year-old man who had recently used heroin and cocaine developed atraumatic rhabdomyolysis, with extensive swelling of his left leg, drowsiness, and agitation [55" ]. He had a high creatine kinase activity and myoglobinuria, and methadone, heroin, and benzodiazepines were found in his urine. The rhabdomyolysis was attributed to the coma, rather than a direct effect of the drugs. 

In an open study in 21 opioid-tolerant patients with severe cancer pain who were switched to methadone, the switch was generally well tolerated only one patient required treatment withdrawal, because of respiratory depression [85 ]. Drowsiness was one of the most frequent adverse effects (in six patients) but it was of moderate intensity and responded to dosage reduction. Constipation was problematic in six. Other effects included nausea and vomiting (n = 2), sweating (n = 2), and confusion (n = 1). 

---